| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
1,124.75
|
|
Change (%)
|
-38.25 (-3.29%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
1,097.50
-
1,167.70
|
|
52-Week Range (RS)
|
581.50
-
1,177.00
|
|
Beta (1 Year)
|
0.51
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE Midcap |
| News |
|
Corporate Details |
| Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Scheme of Arrangement |
| Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Updates |
| Aurobindo Pharma's Rajasthan-based facility concludes US FDA audit with 9 observations |
| USFDA completes inspection of Eugia Pharma Specialities' Unit II |
| Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Updates |
| Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Updates |
| Aurobindo Pharma completes disposal of business assets of Eugia US Manufacturing LLC |
| Aurobindo Pharma update on acquisition of balance stake in Purple Bellflower, South Africa |
| Aurobindo Pharma Ltd spurts 0.18%, gains for five straight sessions |
| Aurobindo Pharma Ltd - Aurobindo Pharma Limited - Updates |
|
|
|
| Incoporation Year : 1986 |
| Chairman : K Ragunathan |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Aurobindo Pharma Ltd
Plot No 2 Maitrivihar,
Behind Maithri Vanam Ameerpet,
Hyderabad,
Telangana-500038 |
Phone:91-40-23736370
Fax:91-40-23747340 |
| E-Mail : cs@aurobindo.com; investorgrievances@aurobindo.com |
| URL : http://www.aurobindo.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
29-Apr-2024 |
1151.80 |
0.97 |
| 1Month |
08-Apr-2024 |
1120.55 |
3.79 |
| 3Month |
06-Feb-2024 |
1015.95 |
14.47 |
| 6Month |
06-Nov-2023 |
873.50 |
33.14 |
| 1Year |
08-May-2023 |
618.90 |
87.91 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| HDFC Mid-Cap Opportunities Fund |
2.17 |
1308.98 |
| Mirae Asset Large & Midcap Fund |
1.61 |
539.70 |
| Quant Mid Cap Fund |
6.94 |
407.80 |
| Quant ELSS Tax Saver Fund |
4.79 |
399.46 |
| ICICI Pru Value Discovery Fund |
0.92 |
377.81 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceuticals Industries Ltd |
1,515.15 |
-0.95 |
1,638.70 |
922.55 |
363,535.24 |
| Cipla Ltd |
1,387.90 |
-2.49 |
1,519.00 |
897.70 |
112,058.35 |
| Dr Reddys Laboratories Ltd |
6,259.15 |
-0.66 |
6,505.50 |
4,383.40 |
104,414.05 |
| Zydus Lifesciences Ltd |
980.65 |
-3.95 |
1,031.30 |
482.55 |
98,676.34 |
| Mankind Pharma Ltd |
2,217.50 |
-2.91 |
2,488.65 |
1,240.75 |
88,830.49 |
|
|
|
|